aspen aerogels inc - ASPN

ASPN

Close Chg Chg %
2.96 0.02 0.68%

Closed Market

2.98

+0.02 (0.68%)

Volume: 698.06K

Last Updated:

Dec 24, 2025, 12:59 PM EDT

Company Overview: aspen aerogels inc - ASPN

ASPN Key Data

Open

$2.97

Day Range

2.92 - 3.00

52 Week Range

2.86 - 14.30

Market Cap

$243.81M

Shares Outstanding

82.65M

Public Float

69.04M

Beta

2.95

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$3.72

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.67M

 

ASPN Performance

1 Week
 
0.34%
 
1 Month
 
-7.76%
 
3 Months
 
-58.17%
 
1 Year
 
-76.18%
 
5 Years
 
-83.23%
 

ASPN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 8
Full Ratings ➔

About aspen aerogels inc - ASPN

Aspen Aerogels, Inc. engages in designing, developing, and manufacturing aerogel insulation used primarily in the energy infrastructure and building materials markets. Its products include Cryogel, Pyrogel, and Spaceloft. It operates through the Energy Industrial and Thermal Barrier segments. The Energy Industrial segment designs, develops and manufactures innovative, high-performance aerogel insulation used primarily in the energy industrial and sustainable insulation markets. The Thermal Barrier segment is actively developing aerogel products and technologies for the EV market. The company was founded by Hamed S. Borhanian, Patrick J. Piper, and Kang P. Lee in May 2001 and is headquartered in Northborough, MA.

ASPN At a Glance

Aspen Aerogels, Inc.
Building B
Northborough, Massachusetts 01532
Phone 1-508-691-1111 Revenue 452.70M
Industry Industrial Specialties Net Income 13.38M
Sector Process Industries 2024 Sales Growth 89.638%
Fiscal Year-end 12 / 2025 Employees 554
View SEC Filings

ASPN Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 71.309
Price to Sales Ratio 2.107
Price to Book Ratio 1.586
Price to Cash Flow Ratio 20.95
Enterprise Value to EBITDA 10.409
Enterprise Value to Sales 2.055
Total Debt to Enterprise Value 0.212

ASPN Efficiency

Revenue/Employee 817,146.209
Income Per Employee 24,142.599
Receivables Turnover 4.149
Total Asset Turnover 0.567

ASPN Liquidity

Current Ratio 3.718
Quick Ratio 3.287
Cash Ratio 2.01

ASPN Profitability

Gross Margin 41.307
Operating Margin 14.346
Pretax Margin 3.333
Net Margin 2.955
Return on Assets 1.674
Return on Equity 2.426
Return on Total Capital 1.647
Return on Invested Capital 1.897

ASPN Capital Structure

Total Debt to Total Equity 32.11
Total Debt to Total Capital 24.306
Total Debt to Total Assets 22.051
Long-Term Debt to Equity 27.709
Long-Term Debt to Total Capital 20.974
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Aspen Aerogels Inc - ASPN

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
121.62M 180.36M 238.72M 452.70M
Sales Growth
+21.29% +48.30% +32.35% +89.64%
Cost of Goods Sold (COGS) incl D&A
111.69M 175.39M 181.80M 265.70M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
11.06M 11.86M 18.18M 24.41M
Depreciation
11.06M 11.86M 18.18M 24.41M
Amortization of Intangibles
- - - -
-
COGS Growth
+30.35% +57.04% +3.65% +46.15%
Gross Income
9.94M 4.98M 56.92M 187.00M
Gross Income Growth
-31.91% -49.92% +1,043.91% +228.52%
Gross Profit Margin
+8.17% +2.76% +23.84% +41.31%
2021 2022 2023 2024 5-year trend
SG&A Expense
50.54M 84.22M 106.12M 122.05M
Research & Development
11.44M 16.93M 16.36M 18.05M
Other SG&A
39.09M 67.29M 89.77M 104.00M
SGA Growth
+39.75% +66.66% +26.01% +15.01%
Other Operating Expense
- - - -
-
Unusual Expense
- - (3.73M) 35.10M
-
EBIT after Unusual Expense
(36.86M) (79.25M) (49.20M) 29.85M
Non Operating Income/Expense
- 1.62M 8.72M (2.80M)
Non-Operating Interest Income
- - 1.62M 6.53M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
229.00K 5.11M 5.33M 11.96M
Interest Expense Growth
-4.58% +2,131.44% +4.27% +124.46%
Gross Interest Expense
229.00K 5.11M 5.33M 11.96M
Interest Capitalized
- - - -
-
Pretax Income
(37.09M) (82.74M) (45.81M) 15.09M
Pretax Income Growth
-70.09% -123.05% +44.63% +132.94%
Pretax Margin
-30.50% -45.87% -19.19% +3.33%
Income Tax
- - - 1.71M
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(37.09M) (82.74M) (45.81M) 13.38M
Minority Interest Expense
- - - -
-
Net Income
(37.09M) (82.74M) (45.81M) 13.38M
Net Income Growth
-70.09% -123.05% +44.63% +129.20%
Net Margin Growth
-30.50% -45.87% -19.19% +2.95%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(37.09M) (82.74M) (45.81M) 13.38M
Preferred Dividends
- - - -
-
Net Income Available to Common
(37.09M) (82.74M) (45.81M) 13.38M
EPS (Basic)
-1.2189 -2.1019 -0.6597 0.1725
EPS (Basic) Growth
-47.42% -72.44% +68.61% +126.15%
Basic Shares Outstanding
30.43M 39.36M 69.44M 77.54M
EPS (Diluted)
-1.2189 -2.1019 -0.6597 0.1666
EPS (Diluted) Growth
-47.42% -72.44% +68.61% +125.25%
Diluted Shares Outstanding
30.43M 39.36M 69.44M 80.31M
EBITDA
(29.54M) (67.38M) (31.03M) 89.36M
EBITDA Growth
-184.05% -128.10% +53.96% +388.01%
EBITDA Margin
-24.29% -37.36% -13.00% +19.74%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 8.75
Number of Ratings 8 Current Quarters Estimate -0.248
FY Report Date 12 / 2025 Current Year's Estimate -4.103
Last Quarter’s Earnings -0.08 Median PE on CY Estimate N/A
Year Ago Earnings 0.17 Next Fiscal Year Estimate -0.408
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 6 5 6 6
Mean Estimate -0.25 -0.18 -4.10 -0.41
High Estimates -0.19 -0.10 -4.05 -0.20
Low Estimate -0.28 -0.22 -4.13 -0.52
Coefficient of Variance -12.84 -25.91 -0.68 -28.95

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 5
OVERWEIGHT 0 0 0
HOLD 2 2 2
UNDERWEIGHT 0 0 0
SELL 1 1 1
MEAN Overweight Overweight Overweight

Insider Actions for Aspen Aerogels Inc - ASPN

Date Name Shares Transaction Value
Mar 12, 2025 Donald R. Young President and CEO; Director 530,856 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $7.95 per share 4,220,305.20
Mar 12, 2025 Virginia H. Johnson CLO, GC, and Secretary 50,579 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $7.95 per share 402,103.05
Mar 12, 2025 Corby C. Whitaker SVP, Sales and Marketing 153,684 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $7.95 per share 1,221,787.80
Mar 12, 2025 Keith L. Schilling SVP, Technology 49,797 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $7.95 per share 395,886.15
Mar 12, 2025 Gregg R. Landes SVP, Operations and Strat Deve 51,207 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $7.95 per share 407,095.65
Mar 12, 2025 Ricardo C. Rodriguez CFO & Treasurer 57,311 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $7.95 per share 455,622.45

Aspen Aerogels Inc in the News